Relevant bibliographies by topics / Infections à Acinetobacter – Chimiothérapie

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Infections à Acinetobacter – Chimiothérapie'

Author: Grafiati
Published: 15 June 2024
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Infections à Acinetobacter – Chimiothérapie.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Infections à Acinetobacter – Chimiothérapie"

1

Wilson, Brigid M., Federico Perez, Qing Pan, Yunyun Jiang, Scott R. Evans, and Robert A. Bonomo. "Acinetobacter Infections." Clinical Infectious Diseases 71, no. 5 (2019): 1357–58. http://dx.doi.org/10.1093/cid/ciz1099.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Snoeck, R., and E. De Clercq. "La chimiothérapie des infections a cytomégalovirus." Médecine et Maladies Infectieuses 18 (March 1988): 79–84. http://dx.doi.org/10.1016/s0399-077x(88)80102-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kempf, M. "Infections à Acinetobacter." EMC - Maladies infectieuses 34, no. 4 (2017): 1–6. https://doi.org/10.1016/s1166-8598(17)73722-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Özgür, Özlem, and Necmi Aksaray. "Acinetobacter Infections and Treatment." Journal of Pediatric Infection 8, no. 1 (2014): 28–32. http://dx.doi.org/10.5152/ced.2013.38.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Joly-Guillou, M. L. "Acinetobacter et infections nosocomiales." Revue Française des Laboratoires 2002, no. 345 (2002): 14. http://dx.doi.org/10.1016/s0338-9898(02)80247-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Falagas, M. E., E. A. Karveli, I. Kelesidis, and T. Kelesidis. "Community-acquired Acinetobacter infections." European Journal of Clinical Microbiology & Infectious Diseases 26, no. 12 (2007): 857–68. http://dx.doi.org/10.1007/s10096-007-0365-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Garnacho-Montero, José, and Jean-François Timsit. "Managing Acinetobacter baumannii infections." Current Opinion in Infectious Diseases 32, no. 1 (2019): 69–76. http://dx.doi.org/10.1097/qco.0000000000000518.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Bergogne-Bérézin, E. "Treatment of Acinetobacter infections." Expert Opinion on Investigational Drugs 6, no. 2 (1997): 119–27. http://dx.doi.org/10.1517/13543784.6.2.119.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gaifer, Zied, Raneem Fallatah, Alhanouf Alanazi, Raghad Alfagi, Lina Alharbi, and Haitham Osman. "Prevalence, Risk Factors, and Outcome of Carbapenem-resistant Acinetobacter Infections in a Community Hospital in Madinah, Saudi Arabia." Saudi Journal of Medicine & Medical Sciences 12, no. 4 (2024): 306–13. http://dx.doi.org/10.4103/sjmms.sjmms_582_23.

Full text
Abstract:
Abstract Background: Acinetobacter is a Gram-negative bacterium that causes nosocomial infections, increasing healthcare costs, patient morbidity, and mortality. The rate of carbapenem resistance among Acinetobacter species is rising in several countries, including Saudi Arabia. Objective: To determine the risk factors and compare the predictors of mortality in patients infected with carbapenem-susceptible and carbapenem-resistant Acinetobacter strains. Materials and Methods: This retrospective study included patients with Acinetobacter infection who were admitted to a community hospital in Ma
APA, Harvard, Vancouver, ISO, and other styles
10

Miah, Md Ruhul Amin. "Acinetobacter baumannii Hospital Acquired Infections." Bangladesh Journal of Medical Microbiology 13, no. 1 (2019): 1–3. http://dx.doi.org/10.3329/bjmm.v13i1.51778.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Infections à Acinetobacter – Chimiothérapie"

1

Antraygues, Kévin. "Conception, synthèse et évaluation biologique de nouveaux ansamacrolides dans le traitement d'infections bactériennes." Electronic Thesis or Diss., Université de Lille (2022-....), 2022. http://www.theses.fr/2022ULILS027.

Full text
Abstract:
L'antibiorésistance est un problème de santé publique majeur à l'heure actuelle et ceci sera d'autant plus vrai dans les prochaines décennies. Parmi les bactéries impliquées dans ce phénomène alarmant, Acinetobacter baumannii et Mycobacterium abscessus ont développé toutes deux des résistantes à de nombreux antibiotiques actuellement disponibles sur le marché. La recherche et le développement de nouveaux antibiotiques est donc nécessaire afin de lutter contre ces pathogènes.La rifabutine, un macrocycle hémisynthétique de la classe des rifamycines, a récemment montré des activités intéressantes
APA, Harvard, Vancouver, ISO, and other styles
2

Henein, Alexandra Elisabeth. "The potential of bacteriophage therapy in Acinetobacter spp. infections." Thesis, University of Brighton, 2009. https://research.brighton.ac.uk/en/studentTheses/9726f331-e5dc-4b67-a282-44cac1fe978f.

Full text
Abstract:
Bacteria resistant to multiple antibiotics pose a number of therapeutic problems. This situation is likely to worsen in the future, as the development of new classes of antibiotics has declined sharply in recent years. Acinetobacter species are an example of antibiotic-resistant bacterial pathogens with increasing clinical significance, particularly with respect to infections in high-risk patients such as those with severe burns. The treatment options for these patients are severely limited, and they often can only be treated with highly toxic antibiotics such as colistin. It is therefore evid
APA, Harvard, Vancouver, ISO, and other styles
3

Diallo, Bruno Salla. "Études des acinetobacter : à propos de 98 souches isolées en milieu hospitalier." Bordeaux 2, 1990. http://www.theses.fr/1990BOR23091.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gagné, Stéphanie. "Étude des mécanismes de virulence du pathogène nosocomial Acinetobacter baumannii." Thesis, Lyon, 2018. http://www.theses.fr/2018LYSE1045/document.

Full text
Abstract:
Acinetobacter baumannii est un pathogène nosocomial qui induit principalement des infections du système respiratoire ou urinaire, et des septicémies chez les patients immunodéprimés. L'émergence de souches multi résistantes aux antibiotiques et l'augmentation de nombreuses d'infections par A. baumannii fait de ce pathogène un enjeu majeur de santé publique. De plus aujourd'hui émerge des souches hypervirulentes. Nous nous sommes intéressés à différentes souches afin de caractériser le phénotype hypervirulent de ces souches. L'étude du système de sécrétion de type VI montre la complexité des mé
APA, Harvard, Vancouver, ISO, and other styles
5

Fabre, David. "Approche pharmacocinétique de l'antibiothérapie dans les infections pulmonaires." Montpellier 1, 1995. http://www.theses.fr/1995MON13504.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hauret, Sylvie. "Epidémiologie moléculaire d'infections nosocomiales à Acinetobacter Baumannii dans un service de réanimation." Bordeaux 2, 1996. http://www.theses.fr/1996BOR2P039.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Webster, Carol Ann. "The use of molecular typing systems for studying the epidemiology of Acinetobacter infections." Thesis, University of Nottingham, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.388315.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Chou, So-ha, and 周素霞. "Molecular epidemiology of carbapenem-resistant acinetobacter baumanniiin patients and their surrounding environment." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B48333669.

Full text
Abstract:
Background There has been an increasing awareness of the role of the hospital environment as a reservoir of Acinetobacter baumannii. A. baumannii is an important nosocomial pathogen and is difficult to control due to the increasing cases of resistance to carbapenem. Objectives The objectives of this study areto examine carbapenem-resistant Acinetobacter baumannii (CRAB) positive patients according to their environmental sample to determine how frequently the environment surrounding the patient becomes contaminated and which environmental surfaces are most commonly contaminated. Methodolog
APA, Harvard, Vancouver, ISO, and other styles
9

Brandely, Marie-Laure. "Nouvelles prises en charge des principales infections fongiques hospitalières : évaluation pharmaco-économique." Paris 5, 1999. http://www.theses.fr/1999PA05P183.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Adegoke, Anthony Ayodeji. "Commensal bacteria belonging to the Staphylococcus Acinetobacter and Stenotrophomonas genera as reservoirs of antibiotic resistance determinants in the environment of Nkonkobe Municipality, Eastern Cape Province , South Africa." Thesis, University of Fort Hare, 2012. http://hdl.handle.net/10353/6539.

Full text
Abstract:
A study to assess the potentials of some commensal bacteria that belong to Staphylococcus, Acinetobacter and Stenotrophomonas genera as reservoirs of antibiotic resistance determinants in the environment of Nkonkobe Municipality of the Eastern Cape Province, South Africa, was carried out using standard microbiological and molecular techniques. A total of 120 Staphylococcus isolates which consisted of Staphylococcus haemolyticus (30%), Staphylococcus aureus (23.3%) from pig; Staphylococcus capitis (15%) from goat; Staphylococcus heamolyticus (5%) and Staphylococcus xylosus (15%) from cattle and
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Infections à Acinetobacter – Chimiothérapie"

1

E, Bergogne-Bérézin, Joly-Guillou M. L, and Towner K. J, eds. Acinetobacter: Microbiology, epidemiology, infections, management. CRC Press, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

E, Bergogne-Bérézin, Friedman Herman 1931-2007, and Bendinelli Mauro, eds. Acinetobacter biology and pathogenesis. Springer, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

E, Bergogne-Bérézin, Friedman Herman 1931-2007, and Bendinelli Mauro, eds. Acinetobacter biology and pathogenesis. Springer, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ulrike, Gerischer, ed. Acinetobacter molecular biology. Caister Academic Press, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jacques, Thèze, and Debré Patrice, eds. Le sida à l'ère des multithérapies. Elsevier, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Dariosecq, Jean-Michel. Infection VIH: Mémento thérapeutique 2003. 6th ed. Doin, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

P, Sawan Samuel, and Manivannan Gurusamy 1960-, eds. Antimicrobial/anti-infective materials: Principles, applications and devices. Technomic Pub. Co., 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Friedman, Herman, Mauro Bendinelli, and Eugénie Bergogne-Bérézin. Acinetobacter: Biology and Pathogenesis. Springer, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bergogne-Berezin, E., Marie-Laure Joly-Guillou, and Kevin J. Towner. Acinetobacter: Microbiology, Epidemiology, Infections, Management. Taylor & Francis Group, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bergogne-Berezin, E., Marie-Laure Joly-Guillou, and Kevin J. Towner. Acinetobacter: Microbiology, Epidemiology, Infections, Management. CRC, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Infections à Acinetobacter – Chimiothérapie"

1

Champion, Howard R., Nova L. Panebianco, Jan J. De Waele, et al. "Acinetobacter Infections." In Encyclopedia of Intensive Care Medicine. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-00418-6_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Dijkshoorn, Lenie. "Acinetobacter baumannii." In Molecular Typing in Bacterial Infections. Humana Press, 2012. http://dx.doi.org/10.1007/978-1-62703-185-1_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Nurjadi, Dennis, and Sébastien Boutin. "Acinetobacter baumannii." In Molecular Typing in Bacterial Infections, Volume II. Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-83217-9_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Joly-Guillou, M. L. "Nosocomial and Community-acquired Acinetobacter Infections." In Acinetobacter Biology and Pathogenesis. Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-77944-7_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Baneman, Emily, and Meenakshi M. Rana. "Management of Acinetobacter Infections in the Immunosuppressed Host." In Emerging Transplant Infections. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-01751-4_21-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Baneman, Emily, and Meenakshi M. Rana. "Management of Acinetobacter Infections in the Immunosuppressed Host." In Emerging Transplant Infections. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-25869-6_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Rajkumari, Jobina, and Busi Siddhardha. "Acinetobacter baumannii: Infections and Drug Resistance." In Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery. Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-1695-5_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rubinstein, E., and I. Levi. "Acinetobacter Infections in Intensive Care Units." In Yearbook of Intensive Care and Emergency Medicine. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-80053-5_44.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Joly-Guillou, M. L., E. Bergogne-Bérézin, and J. F. Vieu. "Epidemiology of Acinetobacter Strains Isolated from Nosocomial Infections in France." In The Biology of Acinetobacter. Springer US, 1991. http://dx.doi.org/10.1007/978-1-4899-3553-3_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Vergidis, Paschalis, and Matthew E. Falagas. "Control of Multi-Drug Resistant Acinetobacter Infections." In Antibiotic Policies. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-1734-8_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Infections à Acinetobacter – Chimiothérapie"

1

Carr, Rachel, Justin Halim, Rebecca Fliorent, Henry Fraimow, Dejan Nikolic, and Valerie Carabetta. "Characterization of Antibiotic Susceptibility Profiles of Extensively- and Pan-Drug Resistant Acinetobacter Baumannii Clinical Isolates." In 27th Annual Rowan-Virtua Research Day. Rowan University Libraries, 2023. https://doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.96_2023.

Full text
Abstract:
Acinetobacter baumannii is an opportunistic pathogen common in intensive care units (ICUs), particularly among immunocompromised individuals. Nosocomial A. baumannii infections have become increasingly problematic in recent years, as these bacteria rapidly acquire antibiotic resistance, leading to the emergence of multidrug, extensively drug and pan drug-resistant (MDR, XDR, and PDR, respectively) isolates. Recently, Cooper University Hospital (CUH) experienced a large increase in highly drug-resistant A. baumannii infections, which had a mortality rate of 60%. Oftentimes, physicians had to tu
APA, Harvard, Vancouver, ISO, and other styles
2

K. Alkhudhairy, Miaad, та Elhassan Benyagoub. "Frequency of Genes Mediated β-lactams Resistance in Acinetobacter Baumannii Isolates from Iraq". У X INTERNATIONAL CONGRESS OF PURE AND APPLIED TECHNOLOGICAL SCIENCES. Rimar Academy, 2023. http://dx.doi.org/10.47832/minarcongress10-2.

Full text
Abstract:
Background: Acinetobacter baumannii is a nosocomial virulent microorganism that can cause acute and chronic infections in burn patients. The aim of the study: Diagnosis of genes mediated β-lactams resistance among test isolates. Materials and Methods: 649 swabs collected from inpatients with burn-wound infections at a burn center in Al-Najaf Province/ Iraq, from August 2022 to February 2023. Results: 68/ 649 (10.5%) isolates of Acinetobacter baumannii were identified according to microscopically, cultural, and biochemical features. 22 (32.4%) isolates were found able to produce extended-spectr
APA, Harvard, Vancouver, ISO, and other styles
3

Al-Ghanimi, Ali Abdul Kadhim, and Amaal Sahib Al-Zughaibi. "Molecular Identification of Acinetobacter baumannii and Staphylococcus aureus isolated from wound infections in Karbala governorate Iraq." In THE 9TH INTERNATIONAL CONFERENCE ON APPLIED SCIENCE AND TECHNOLOGY (ICAST 2021). AIP Publishing, 2022. http://dx.doi.org/10.1063/5.0113631.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Vrancianu, Corneliu Ovidiu, Roxana-Elena Cristian, Elena-Georgiana Dobre, et al. "The Impact of Acinetobacter baumannii Infections in COVID-19 Patients Admitted in Hospital Intensive Care Units." In ECM 2023. MDPI, 2023. http://dx.doi.org/10.3390/ecm2023-16479.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Saad Jabbar, Bashaer. "Molecular Epidemiology and Risk Factors for Carbapenem-Resistant Acinetobacter baumannii Infections in an Intensive Care Unit." In II. Dubai International Conference of Pure, Applied and Technological Sciences. Rimar Academy, 2025. https://doi.org/10.47832/dub.conf2-1.

Full text
Abstract:
Carbapenem-resistant Acinetobacter baumannii (CRAB) poses a significant threat to global health, particularly in intensive care units (ICUs). This study investigated the molecular epidemiology and risk factors associated with CRAB infections in four Iraqi ICUs. A total of 164 patients with invasive MDR A. baumannii infections were included. Demographic and clinical data were collected prospectively, and antimicrobial susceptibility testing was performed on 172 isolates (164 clinical and 8 environmental). Multiplex PCR was used to identify four key carbapenem resistance genes. The study reveale
APA, Harvard, Vancouver, ISO, and other styles
6

Jonnalagadda, Keertana, Rachel Carr, and Valerie Carabetta. "Evaluation of the Efficacy of Novel Drugs and Combinations Against Extensively- and Pan-Drug Resistant Acinetobacter baumannii Isolates." In 28th Annual Rowan-Virtua Research Day. Rowan University Libraries, 2024. http://dx.doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.110_2024.

Full text
Abstract:
Acinetobacter baumannii, a Gram-negative, nosocomial, opportunistic pathogen is commonly infectious in immunocompromised patients. More specifically patients develop healthcare-associated infections (HAI) spanning beyond sepsis, pneumonia, meningitis, and urinary tract infections. Due to its rapid ability to acquire antibiotic resistance, it has raised the necessity to discern a novel therapeutic treatment that can be effectively used against the multidrug resistant (MDR) A. baumannii. Cooper University Hospital (CUH) faced an increased case load of patients that were infected with MDR A. baum
APA, Harvard, Vancouver, ISO, and other styles
7

Grosse-Onnebrink, Joerg, Heymut Omran, Johanna Rudloff, and Claudius Werner. "Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa4137.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hodyna, Diana. "LONG-CHAIN TRIPHENYLPHOSPHONIUM IONIC LIQUIDS AS ANTIBACTERIALS IN POTENTIAL POLYMICROBIAL INFECTIONS CAUSED BY STAPHYLOCOCCUS AUREUS AND ACINETOBACTER BAUMANNII STRAINS." In THEORETICAL AND PRACTICAL ASPECTS OF MODERN SCIENTIFIC RESEARCH, chair Ivan Semenyuta, Sergiy Rogalsky, and Larysa Metelytsia. European Scientific Platform, 2023. http://dx.doi.org/10.36074/logos-28.04.2023.26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Misri, A. R. "To Study the Epidemiology of Multidrug Resistant Acinetobacter Infections Among Critically Ill Adult Patients Admitted in Medical Intensive Care Unit." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6508.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Dragovac, Gorana, Smiljana Rajčević, Jelena Đekić-Malbaša, et al. "Health care associated infections: One of the major public health challenges in Vojvodina Province, Serbia." In Proceedings of the International Congress Public Health - Achievements and Challenges. Institute of Public Health of Serbia "Dr Milan Jovanović Batut", 2024. http://dx.doi.org/10.5937/batutphco24130d.

Full text
Abstract:
Background: Nosocomial or health care associated infections (HAIs) occur in all hospitals in the world. Integrated infection control program, with HAI surveillance as its cornestone, can reduce the incidence of HAIs as significant public health challange and contribute to economic benefits. Aim of the paper is to report the prevalence and epidemiological features of HAI in Vojvodina hospitals. Methods and Objectives: Synchronous point prevalence study (PPS), in all hospitals in Vojvodina province in November 2022, according to the Fifth National PPS and the Second European PPS. The study popul
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Infections à Acinetobacter – Chimiothérapie"

1

Meddaugh, Paul, and Uzo Chukwuma. Acinetobacter Species Infections Among Navy and Marine Corps Beneficiaries: 2013 Annual Report. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada611595.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Meddaugh, Paul, and Uzo Chukwuma. Acinetobacter Species Infections among Navy and Marine Corps Beneficiaries: 2014 Annual Report. Defense Technical Information Center, 2015. http://dx.doi.org/10.21236/ada621496.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Maraolo, Alberto Enrico, and David SY Ong. Colistin plus meropenem versus colistin alone for invasive infections caused by Carbapenem-Resistant Acinetobacter baumannii: a rapid systematic review of randomized controlled trials using Bayesian meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.1.0055.

Full text
Abstract:
Review question / Objective: What is the benefit stemming from meropenem add-on treatment to colistin against Carbapenem-Resistant strains of Acinetobacter baumannii? Condition being studied: Invasive infections caused by extensively drug-resistant (XDR) Acinetobacter baumannii, specifically carbapenem-resistant Acinetobacter baumannii (CRAB), are associated with high mortality above 50%, especially in critically ill patients. Often colistin is the only active agent in vitro and, although its safety issues, remains the cornerstone of therapy. Nevertheless, considering the relevant mortality ra
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Infections à Acinetobacter – Chimiothérapie' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography